Syndax Pharmaceuticals Inc

NASDAQ:SNDX  
22.17
-0.62 (-2.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.04B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.3 Million
Adjusted EPS-$0.64
See more estimates
10-Day MA$23.03
50-Day MA$22.69
200-Day MA$19.48
See more pivots

Syndax Pharmaceuticals, Inc. Stock, NASDAQ:SNDX

35 Gatehouse Drive, Building D, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.419.1400
Number of Employees: 35

Description

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.